Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate Microgranules (Micropakine SR) in Pediatric Epilepsy
NCT00385411Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of valproic acid in epilepsy, sponsored by Sanofi. Primary endpoint: Clinical and biological safety. Started Mar 2006; status: completed.
02
Drugs
valproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00385411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385411.